Michael S. Hofman

2003–2026 年に発表

188
論文数
22,707
被引用数
78
h 指数
172
i10 指数

被引用数

Michael S. Hofman の年別被引用数1998 年: 被引用 1 件2003 年: 被引用 1 件2004 年: 被引用 1 件2005 年: 被引用 1 件2006 年: 被引用 4 件2007 年: 被引用 1 件2008 年: 被引用 2 件2009 年: 被引用 4 件2010 年: 被引用 5 件2011 年: 被引用 3 件2012 年: 被引用 9 件2013 年: 被引用 23 件2014 年: 被引用 35 件2015 年: 被引用 44 件2016 年: 被引用 33 件2017 年: 被引用 110 件2018 年: 被引用 148 件2019 年: 被引用 586 件2020 年: 被引用 893 件2021 年: 被引用 1,271 件2022 年: 被引用 1,016 件2023 年: 被引用 904 件2024 年: 被引用 1,785 件2025 年: 被引用 998 件2026 年: 被引用 19 件1999〜2002 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 1,506 件、この内訳の 17.7%ドイツ: 引用元論文 903 件、この内訳の 10.6%イタリア: 引用元論文 580 件、この内訳の 6.8%オーストラリア: 引用元論文 537 件、この内訳の 6.3%中国: 引用元論文 514 件、この内訳の 6%イギリス: 引用元論文 478 件、この内訳の 5.6%オランダ: 引用元論文 388 件、この内訳の 4.5%スイス: 引用元論文 357 件、この内訳の 4.2%フランス: 引用元論文 356 件、この内訳の 4.2%カナダ: 引用元論文 334 件、この内訳の 3.9%ベルギー: 引用元論文 202 件、この内訳の 2.4%オーストリア: 引用元論文 190 件、この内訳の 2.2%
0%17.7%その他 25.6%

分野

  • Medicine91%
  • Biochemistry, Genetics and Molecular Biology3.7%
  • Physics and Astronomy1.2%
  • Engineering1%
  • Computer Science1%
  • Immunology and Microbiology0.6%
  • その他1.5%

トピック

  • Prostate Cancer Treatment and Research17.9%
  • Radiopharmaceutical Chemistry and Applications13.3%
  • Prostate Cancer Diagnosis and Treatment11.4%
  • Medical Imaging Techniques and Applications4.6%
  • Neuroendocrine Tumor Research Advances3.7%
  • Radiomics and Machine Learning in Medical Imaging2.4%
  • その他46.7%

共著者

全論文

検索で開く
  1. Prostate-specific membrane antigen PET-CT in patients with high-risk prostate cancer before curative-intent surgery or radiotherapy (proPSMA): a prospective, randomised, multicentre study

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , - The Lancet 2020 被引用: 1,962

  2. [177Lu]Lu-PSMA-617 versus cabazitaxel in patients with metastatic castration-resistant prostate cancer (TheraP): a randomised, open-label, phase 2 trial

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Andrew Martin, Ian D. Davis, Arun Azad, Wei Chua, Ian D. Davis, Nattakorn Dhiantravan, Louise Emmett, Kate Ford, Michael S. Hofman, Roslyn J. Francis, Craig Gedye, Jeffrey C. Goh, Alex Guminski, Edward Hsiao, Amir Iravani, Anthony M. Joshua, Ian Kirkwood, Ailsa Langford, Nicola Jane Lawrence, Sze-Ting Lee, Peter Lin, Andrew Martin, William M. McDonald, Margaret McJannett, Siobhan Ng, David A. Pattison, Shakher Ramdave, Nisha Rana, Andrew Redfern, Natalie Rutherford, Shahneen Sandhu, Andrew M. Scott, Martin R. Stockler, Shalini Subramaniam, Thean Hsiang Tan, John Violet, Andrew Weickhardt, Scott Williams, Sonia Yip, Alison Y. Zhang - The Lancet 2021 被引用: 1,082

  3. The Lancet Commission on prostate cancer: planning for the surge in cases

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Anwar R. Padhani, Charles Parker, Hannah Rush, Mark Sculpher, Howard R. Soule, Matthew R. Sydes, Derya Tilki, Nina Tunariu, Paul Villanti, Liping Xie - The Lancet 2024 被引用: 643

  4. [177Lu]-PSMA-617 radionuclide treatment in patients with metastatic castration-resistant prostate cancer (LuPSMA trial): a single-centre, single-arm, phase 2 study

    著者: , , , , , , , , , , , , , , - The Lancet Oncology 2018 被引用: 1,143

  5. Dosimetry of 177Lu-PSMA-617 in Metastatic Castration-Resistant Prostate Cancer: Correlations Between Pretherapeutic Imaging and Whole-Body Tumor Dosimetry with Treatment Outcomes

    著者: , , , , , , , , , , , , , , - Journal of Nuclear Medicine 2018 被引用: 486

  6. Gallium-68 Prostate-specific Membrane Antigen Positron Emission Tomography in Advanced Prostate Cancer—Updated Diagnostic Utility, Sensitivity, Specificity, and Distribution of Prostate-specific Membrane Antigen-avid Lesions: A Systematic Review and Meta-analysis

    著者: , , , , , , , , , , - European Urology 2019 被引用: 952

  7. PSMA and FDG-PET as predictive and prognostic biomarkers in patients given [177Lu]Lu-PSMA-617 versus cabazitaxel for metastatic castration-resistant prostate cancer (TheraP): a biomarker analysis from a randomised, open-label, phase 2 trial

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Jeffrey C. Goh, Alex Guminski, Anis Hamid, Mohammad B. Haskali, Rodney J. Hicks, Edward Hsiao, Amir Iravani, Anthony M. Joshua, Ian Kirkwood, Grace Kong, Edmond M. Kwan, Ailsa Langford, Nicola Jane Lawrence, Sze-Ting Lee, Jeremy Lewin, Peter Lin, Andrew Martin, William M. McDonald, Margaret McJannett, Kate Moodie, Declan G. Murphy, Siobhan Ng, David A. Pattison, Izabella Pokorski, Shakher Ramdave, Aravind S. Ravi Kumar, Andrew Redfern, Natalie Rutherford, Javad Saghebi, Shahneen Sandhu, Andrew M. Scott, Lavinia Spain, Martin R. Stockler, Shalini Subramaniam, Thean Hsiang Tan, Sue Ping Thang, Ben Tran, Roslyn E. Wallace, Andrew Weickhardt, Scott Williams, Sonia Yip, Alison Y. Zhang, Sonia Yip, Alison Y. Zhang - The Lancet Oncology 2022 被引用: 266

  8. The Additive Diagnostic Value of Prostate-specific Membrane Antigen Positron Emission Tomography Computed Tomography to Multiparametric Magnetic Resonance Imaging Triage in the Diagnosis of Prostate Cancer (PRIMARY): A Prospective Multicentre Study

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Michael S. Hofman, Phillip D. Stricker - European Urology 2021 被引用: 418

  9. Joint EANM/SNMMI procedure guideline for the use of 177Lu-labeled PSMA-targeted radioligand-therapy (177Lu-PSMA-RLT)

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , - European Journal of Nuclear Medicine and Molecular Imaging 2023 被引用: 255

  10. Second Version of the Prostate Cancer Molecular Imaging Standardized Evaluation Framework Including Response Evaluation for Clinical Trials (PROMISE V2)

    著者: , , , , , , , , , , , , , , , , , - European Urology 2023 被引用: 276

  11. Overall survival with [177Lu]Lu-PSMA-617 versus cabazitaxel in metastatic castration-resistant prostate cancer (TheraP): secondary outcomes of a randomised, open-label, phase 2 trial

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Ian D. Davis, Tim Akhurst, Ramin Alipour, Dale L. Bailey, Patricia Banks, Alexis Beaulieu, Louise Campbell, Megan Crumbaker, Nattakorn Dhiantravan, Anis Hamid, Mohammad B. Haskali, Terry Hung, Grace Kong, Nick Lawrence, Jeremy Lewin, Michael McCarthy, Kate Moodie, Declan G. Murphy, Andrew Nguyen, David Pook, Aravind Ravi Kumar, Paul Roach, Peter Roselt, Javad Saghebi, Geoffrey Schembri, Lavinia Spain, Shalini Subramaniam, Sue Ping Thang, Paul Thomas, Ben Tran, Roslyn E. Wallace, Sonia Yip - The Lancet Oncology 2023 被引用: 199

  12. Management of patients with advanced prostate cancer—metastatic and/or castration-resistant prostate cancer: Report of the Advanced Prostate Cancer Consensus Conference (APCCC) 2022

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Noel W. Clarke, Gedske Daugaard, Maria De Santis, Ignacio Durán, Ross Eeles, Eleni Efstathiou, Jason A. Efstathiou, Onyeanunam Ngozi Ekeke, Christopher P. Evans, Stefano Fanti, Felix Y. Feng, Valérie Fonteyne, Nicola Fossati, Mark Frydenberg, Dan George, Martin Gleave, Gwénaëlle Gravis, Susan Halabi, Daniel Heinrich, Ken Herrmann, Celestia Higano, Michael S. Hofman, Lisa G. Horvath, Maha Hussain, Barbara Alicja Jereczek‐Fossa, Robert J. Jones, Ravindran Kanesvaran, Pirkko‐Liisa Kellokumpu‐Lehtinen, Raja B. Khauli, Laurence Klotz, Gero Kramer, Raja Leibowitz, Christopher Logothetis, Brandon A. Mahal, Fernando Cotait Maluf, Joaquı́n Mateo, David Matheson, Niven Mehra, Axel S. Merseburger, Amee Morgans, Michael J. Morris, Hind M’rabti, Deborah Mukherji, Declan G. Murphy, Vedang Murthy, Paul L. Nguyen, William Oh, Piet Ost, Joe M. O’Sullivan, Anwar R. Padhani, Carmel Pezaro, Darren M.C. Poon, Colin C. Pritchard, Danny Rabah, Dana E. Rathkopf, Robert E. Reiter, Mark A. Rubin, Charles J. Ryan, Fred Saad, Juan Pablo Sade, Oliver Sartor, Howard I. Scher, Nima Sharifi, Iwona Skoneczna, Howard R. Soule, Daniel E. Spratt, Sandy Srinivas, Cora N. Sternberg, Thomas Steuber, Hiroyoshi Suzuki ほか 18 名 - European Journal of Cancer 2023 被引用: 157

  13. Nomograms to predict outcomes after 177Lu-PSMA therapy in men with metastatic castration-resistant prostate cancer: an international, multicentre, retrospective study

    著者: , , , , , , , , , , , , , , , , , , , , , , , , - The Lancet Oncology 2021 被引用: 246

  14. E-PSMA: the EANM standardized reporting guidelines v1.0 for PSMA-PET

    著者: , , , , , , , , , , , , , , - European Journal of Nuclear Medicine and Molecular Imaging 2021 被引用: 359

  15. Long-Term Follow-up and Outcomes of Retreatment in an Expanded 50-Patient Single-Center Phase II Prospective Trial of 177Lu-PSMA-617 Theranostics in Metastatic Castration-Resistant Prostate Cancer

    著者: , , , , , , , , , , , , , , , , , , , , - Journal of Nuclear Medicine 2019 被引用: 286

  16. Head-to-head Comparison of the Diagnostic Accuracy of Prostate-specific Membrane Antigen Positron Emission Tomography and Conventional Imaging Modalities for Initial Staging of Intermediate- to High-risk Prostate Cancer: A Systematic Review and Meta-analysis

    著者: , , , , , , , , , , , , , , - European Urology 2023 被引用: 176

  17. [177Lu]Lu-PSMA-617 plus enzalutamide in patients with metastatic castration-resistant prostate cancer (ENZA-p): an open-label, multicentre, randomised, phase 2 trial

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Alison Yan Zhang, Sonia Yip, Hayley Thomas, Ailsa Langford, Michael S. Hofman, Margaret McJannett, Andrew Martin, Martin R. Stockler, Ian D. Davis - The Lancet Oncology 2024 被引用: 155

  18. 18F-fluciclovine PET-CT and 68Ga-PSMA-11 PET-CT in patients with early biochemical recurrence after prostatectomy: a prospective, single-centre, single-arm, comparative imaging trial

    著者: , , , , , , , , , , , , , , , , , , , , , - The Lancet Oncology 2019 被引用: 469

  19. Sensitivity, Specificity, and Predictors of Positive 68 Ga–Prostate-specific Membrane Antigen Positron Emission Tomography in Advanced Prostate Cancer: A Systematic Review and Meta-analysis

    著者: , , , , , , , - European Urology 2016 被引用: 1,002

  20. Radiation Dosimetry in 177Lu-PSMA-617 Therapy Using a Single Posttreatment SPECT/CT Scan: A Novel Methodology to Generate Time- and Tissue-Specific Dose Factors

    著者: , , , , - Journal of Nuclear Medicine 2019 被引用: 137

  21. Management of Patients with Advanced Prostate Cancer. Part I: Intermediate-/High-risk and Locally Advanced Disease, Biochemical Relapse, and Side Effects of Hormonal Treatment: Report of the Advanced Prostate Cancer Consensus Conference 2022

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Noel W. Clarke, Gedske Daugaard, Maria De Santis, Ignacio Durán, Rosalind A. Eeles, Eleni Efstathiou, Jason A. Efstathiou, Onyeanunam Ngozi Ekeke, Christopher P. Evans, Stefano Fanti, Felix Y. Feng, Valérie Fonteyne, Nicola Fossati, Mark Frydenberg, Daniel J. George, Martin Gleave, Gwénaëlle Gravis, Susan Halabi, Daniel Heinrich, Ken Herrmann, Celestia S. Higano, Michael S. Hofman, Lisa G. Horvath, Maha Hussain, Barbara Alicja Jereczek‐Fossa, Robert J. Jones, Ravindran Kanesvaran, Pirkko‐Liisa Kellokumpu‐Lehtinen, Raja B. Khauli, Laurence Klotz, Gero Kramer, Raya Leibowitz‐Amit, Christopher J. Logothetis, Brandon A. Mahal, Fernando Cotait Maluf, Joaquı́n Mateo, David Matheson, Niven Mehra, Axel S. Merseburger, Alicia K. Morgans, Michael J. Morris, Hind M’rabti, Deborah Mukherji, Declan G. Murphy, Vedang Murthy, Paul L. Nguyen, William Oh, Piet Ost, Joe M. O’Sullivan, Anwar R. Padhani, Carmel Pezaro, Darren M.C. Poon, Colin C. Pritchard, Danny Rabah, Dana E. Rathkopf, Robert E. Reiter, Mark A. Rubin, Charles J. Ryan, Fred Saad, Juan Pablo Sade, Oliver A. Sartor, Howard I. Scher, Nima Sharifi, Iwona Skoneczna, Howard R. Soule, Daniel E. Spratt, Sandy Srinivas, Cora N. Sternberg, Thomas Steuber, Hiroyoshi Suzuki ほか 18 名 - European Urology 2022 被引用: 118

  22. Prostate-Specific Membrane Antigen Ligand Positron Emission Tomography in Men with Nonmetastatic Castration-Resistant Prostate Cancer

    著者: , , , , , , , , , , , , , , , , , , , - Clinical Cancer Research 2019 被引用: 267

  23. Radiotherapy and theranostics: a Lancet Oncology Commission

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , David A. Jaffray, Peter Knoll, Jolanta Kunikowska, Jason S. Lewis, Yolande Lievens, Miriam Mikhail-Lette, Dennis A. Ostwald, Jatinder Palta, Platon Peristeris, Arthur Accioly Rosa, Soha Ahmed Salem, Marcos Augusto dos Santos, Mike Sathekge, Shyam Kishore Shrivastava, Egor Titovich, Jean-Luc Urbain, Verna Vanderpuye, Richard L. Wahl, Jennifer S. Yu, Mohamed S. Zaghloul, Hongcheng Zhu, Andrew M. Scott - The Lancet Oncology 2024 被引用: 120

  24. Using PSMA imaging for prognostication in localized and advanced prostate cancer

    著者: , , , , , , , , , , - Nature Reviews Urology 2022 被引用: 83